Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a cash flow conversion efficiency ratio of -0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-17.57 Million ≈ $-2.57 Million USD) by net assets (CN¥756.82 Million ≈ $110.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Gansu Longshenrongfa Pharmaceutical Indu (300534) strategic asset index to assess the company's strategic physical and investment asset allocation.
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See Gansu Longshenrongfa Pharmaceutical Indu book value and equity for net asset value and shareholders' equity analysis.
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Elitegroup Computer Systems Co Ltd
TW:2331
|
0.005x |
|
Brunel International NV
AS:BRNL
|
0.153x |
|
Jiangsu Gaoke Petrochemical Co
SHE:002778
|
0.114x |
|
Southern States Bancshares Inc
NASDAQ:SSBK
|
0.033x |
|
Dredging Corporation of India Limited
NSE:DREDGECORP
|
0.151x |
|
3D Systems Corporation
NYSE:DDD
|
-0.061x |
|
Modern Avenue Group Co Ltd
SHE:002656
|
-0.380x |
|
Fastighets AB Trianon (publ)
ST:TRIAN-B
|
0.014x |
Annual Cash Flow Conversion Efficiency for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Gansu Longshenrongfa Pharmaceutical Indu (300534) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥781.08 Million ≈ $114.30 Million |
CN¥-6.54 Million ≈ $-956.57K |
-0.008x | -103.58% |
| 2024-12-31 | CN¥727.93 Million ≈ $106.52 Million |
CN¥170.14 Million ≈ $24.90 Million |
0.234x | +72.29% |
| 2023-12-31 | CN¥711.51 Million ≈ $104.12 Million |
CN¥96.53 Million ≈ $14.12 Million |
0.136x | +806.01% |
| 2022-12-31 | CN¥763.13 Million ≈ $111.67 Million |
CN¥11.43 Million ≈ $1.67 Million |
0.015x | -78.54% |
| 2021-12-31 | CN¥732.84 Million ≈ $107.24 Million |
CN¥51.13 Million ≈ $7.48 Million |
0.070x | +18.56% |
| 2020-12-31 | CN¥739.13 Million ≈ $108.16 Million |
CN¥43.50 Million ≈ $6.37 Million |
0.059x | +54.16% |
| 2019-12-31 | CN¥738.88 Million ≈ $108.12 Million |
CN¥28.21 Million ≈ $4.13 Million |
0.038x | +168.93% |
| 2018-12-31 | CN¥720.83 Million ≈ $105.48 Million |
CN¥10.23 Million ≈ $1.50 Million |
0.014x | +592.28% |
| 2017-12-31 | CN¥712.19 Million ≈ $104.22 Million |
CN¥-2.05 Million ≈ $-300.53K |
-0.003x | -115.45% |
| 2016-12-31 | CN¥703.74 Million ≈ $102.98 Million |
CN¥13.14 Million ≈ $1.92 Million |
0.019x | -75.26% |
| 2015-12-31 | CN¥405.57 Million ≈ $59.35 Million |
CN¥30.60 Million ≈ $4.48 Million |
0.075x | -29.77% |
| 2014-12-31 | CN¥363.10 Million ≈ $53.13 Million |
CN¥39.01 Million ≈ $5.71 Million |
0.107x | -4.61% |
| 2013-12-31 | CN¥318.92 Million ≈ $46.67 Million |
CN¥35.92 Million ≈ $5.26 Million |
0.113x | -45.79% |
| 2012-12-31 | CN¥171.46 Million ≈ $25.09 Million |
CN¥35.62 Million ≈ $5.21 Million |
0.208x | -7.30% |
| 2011-12-31 | CN¥45.35 Million ≈ $6.64 Million |
CN¥10.16 Million ≈ $1.49 Million |
0.224x | -- |
About Gansu Longshenrongfa Pharmaceutical Industry Co Ltd
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally. It is also involved in the cultivation, processing, and sales of chemical drugs and medicinal herbs, as well as pharmaceutical distribution, testing, and inspection services. The company was founded in 2002… Read more